Q2 2024 Holdings
Filed 2024-08-14 | 33 holdings | $118.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $19.0M | 2,771,130 | 16.0% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $9.3M | 397,698 | 7.8% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $8.3M | 110,400 | 7.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $7.5M | 212,500 | 6.3% |
| Praxis Precision Medicines I(PRAX) | COM | 74006W207 | $6.8M | 164,431 | 5.7% |
| Crinetics Pharmaceuticals(CRNX) | COM | 22663K107 | $6.1M | 135,141 | 5.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $5.4M | 250,370 | 4.5% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $5.2M | 2,330,937 | 4.4% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $5.2M | 133,000 | 4.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $4.8M | 72,100 | 4.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $4.3M | 27,500 | 3.7% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $3.5M | 269,614 | 2.9% |
| Agios Pharma(AGIO) | COM | 00847X104 | $3.4M | 78,700 | 2.9% |
| Kura Oncology Inc. Common Stock(KURA) | COM | 50127T109 | $3.4M | 163,000 | 2.8% |
| Mersana Therapeutics Inc | COM | 59045L106 | $3.3M | 1,663,000 | 2.8% |
| Corbus Pharmaceuticals Holdi(CRBP) | COM NEW | 21833P301 | $2.9M | 64,500 | 2.5% |
| Aadi Biosciences Inc(WHWK) | COM | 00032Q104 | $2.7M | 1,849,402 | 2.3% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $2.6M | 199,433 | 2.2% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $2.5M | 369,280 | 2.1% |
| Mereo Biopharma Group PL(MREO) | SPON ADS | 589492107 | $2.4M | 677,000 | 2.1% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $2.3M | 42,200 | 2.0% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $1.8M | 177,836 | 1.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $1.7M | 4,000 | 1.4% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $774.8K | 260,000 | 0.7% |
| Celcuity Inc(CELC) | COM | 15102K100 | $737.1K | 45,000 | 0.6% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $678.7K | 96,000 | 0.6% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $496.7K | 46,200 | 0.4% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $465.2K | 20,000 | 0.4% |
| Newamsterdam Pharma Co NV(NAMS) | ORDINARY SHARES | N62509109 | $432.2K | 22,500 | 0.4% |
| Leap Therapeutics Inc(CYPH) | COM NEW | 52187K200 | $382.2K | 195,000 | 0.3% |
| Cellectar Biosciences Inc.(CLRBUSD) | COM NEW | 15117F807 | $176.3K | 70,500 | 0.1% |
| Savara Inc(SVRA)Put | COM | 805111101 | $100.8K | 250 | 0.1% |
| Nuvation BIO Inc -Cw27(NUVB/WS) | *W EXP 07/07/2027 | 67080N119 | $14.5K | 90,832 | 0.0% |